ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
adreamer
|
24 |
7.0K |
12 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
7.0K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
35 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
978
|
268K
|
35
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
adreamer
|
24 |
7.0K |
6 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
7.0K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
21 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
978
|
268K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
adreamer
|
85 |
22K |
43 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
22K
|
43
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
adreamer
|
85 |
22K |
16 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
22K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
18 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
978
|
268K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
19 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
978
|
268K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
8 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
978
|
268K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
12 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
978
|
268K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
9 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
978
|
268K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
978
|
268K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
28 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
978
|
268K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
30 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
978
|
268K
|
30
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
28 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
978
|
268K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
9 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
978
|
268K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
16 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
978
|
268K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
978
|
268K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
978
|
268K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appointment of Company Secretary
|
|
adreamer
|
4 |
2.0K |
14 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4
|
2.0K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
13 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
978
|
268K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
24 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
978
|
268K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
54 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
978
|
268K
|
54
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
13 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
58
|
17K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
8 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
978
|
268K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
14 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
17 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
14 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
12 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
15 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
58
|
17K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
17 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
22 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
268K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
4 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
58
|
17K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
8 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
58
|
17K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
12 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
58
|
17K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
7 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
58
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
8 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
58
|
17K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
18 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
58
|
17K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
21 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
978
|
268K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
16 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
268K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
23 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
268K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
11 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
14 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
12 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
11 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
268K |
18 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
268K
|
18
|
|